Au8, an experimental ALS therapy. CNM-Au8 has been associated with NfL reductions, a biomarker finding linked to longer ...

PIONEER-ALS, a clinical trial evaluating VTx-002 as a treatment for ALS, has been given a green light to launch study sites in three European nations. The therapy targets toxic TDP-43 protein clumps, ...

New ALS drug enters human trials after reversing a key protein in animals and could change the future of treatment.

A progenitor-derived corticospinal-like neuron in cell culture, extending its long axon, even in isolation. The cell body (or "soma"; immunolabeled by Tuj1 antibody in red) is at the top, with the ...

Peripheral nerve injuries, often caused by traumatic events such as car accidents, falls or battlefield injuries, can leave patients with long-term weakness, numbness or loss of function. Despite ...